ReviewPharmaceuticals (Basel, Switzerland)2024

CRISPR/Cas9 Technology Providing the Therapeutic Landscape of Metastatic Prostate Cancer.

Jieun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.